Ph.D. candidate Anna Moyer reflects on the bittersweet outcome of a clinical trial in children with Down syndrome.
Since pharmaceutical companies began rebranding the pill in the 1990s, use of hormonal birth control for noncontraceptive purposes has exploded. But what has that done to women’s understanding of their own bodies?
Ph.D. candidate Roshan Chikarmane identifies key drivers of rising drug prices and introduces corresponding interventions that are being undertaken by business leaders to shift industry trends toward more affordable health care.
Here’s how a group of passionate thinkers turned scholarly insights into therapies that could help millions of patients with heart failure.
Imagine a scenario where a patient comes into the clinic with a suspected cancer. The clinician not only confirms that the patient does indeed have… Read More »Clinical trial to target cancer drugs to gene mutations for individualized therapy